Integer Holdings Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: $105.43 High: $107.76
on August 1, 2025

52 Week Range

Low: $104.93 High: $146.36
on April 8, 2025
on January 30, 2025

All-Time High: $146.36 on January 27, 2025

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $3.7B
EPS i 2.34
P/E Ratio (TTM) i 45.52
Forward P/E i 17.58
P/B Ratio i 2.19
PEG Ratio i 17.58
Div. Yield i N/A
ROE i 5.15%
Beta i 0.980
Debt to Equity i 77.55

Financial Highlights

Profitability

Gross Margin i 27.10%
Operating Margin i 13.42%
Profit Margin i 4.61%

Returns and Earnings

Return on Assets (TTM) i 4.60%
Return on Equity (TTM) i 5.15%
EBITDA i $297.7M
Net Income (TTM) i $83.8M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i $53.50
Quarterly Revenue Growth (YoY) i 11.40%
Quarterly Earnings Growth (YoY) i 18.40%

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Integer Holdings ITGR 3.73B Mid-cap-1.83%-12.18%-15.18%-22.95%-19.41%-4.70%50.11%63.93%
Abbott Laboratories ABT 221.54B Mega-cap0.59%-6.58%-2.74%-0.90%12.21%14.36%16.51%25.74%
Boston Scientific BSX 155.95B Large-cap-0.69%0.60%2.15%2.27%17.93%41.49%157.47%170.49%
Penumbra PEN 9.48B Mid-cap4.25%-3.06%-16.73%-8.30%1.26%38.46%45.66%3.76%
Masimo MASI 8.35B Mid-cap-6.48%-8.91%-5.93%-10.57%-8.67%44.77%0.32%-29.08%
Bio-Rad Laboratories BIO 7.57B Mid-cap7.73%14.76%18.37%-19.40%-12.74%-15.28%-47.26%-45.70%

Ownership & Short Interest

Insider Ownership i 0.89%
Institutional Ownership i 115.86%
Shares Short i 3M
Short Ratio i 5.99
Short % of Shares Outstanding i 10.45%
Average 10-Day Volume i 627K
Average 90-Day Volume i 511K

Integer Holdings Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Integer Holdings would have performed over time.

$
If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Integer Holdings reached a high of $146.36 (on January 30, 2025) and a low of $104.93 (on April 8, 2025).
Curious about Integer Holdings's size and valuation? Its market capitalization stands at 3.73B. When it comes to valuation, the P/E ratio (trailing twelve months) is 45.52, and the forward P/E (looking ahead) is 17.58.
As for dividends, Integer Holdings isn't currently offering a significant yield, or that specific data isn't available right now.

When looking at Integer Holdings, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Abbott Laboratories
ABT
221.54BHealthcareMedical Devices14.36%16.51%
Boston Scientific
BSX
155.95BHealthcareMedical Devices41.49%157.47%
Penumbra
PEN
9.48BHealthcareMedical Devices38.46%45.66%
Masimo
MASI
8.35BHealthcareMedical Devices44.77%0.32%
Bio-Rad Laboratories
BIO
7.57BHealthcareMedical Devices-15.28%-47.26%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Integer Holdings's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.15%, the Debt to Equity ratio from the most recent quarter is 77.55, and its Gross Profit Margin stands at 27.10%.
Looking at Integer Holdings's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 11.40%, and quarterly earnings saw a YoY growth of 18.40%.
Wondering who owns Integer Holdings stock? Company insiders (like executives and directors) hold about 0.89% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 115.86%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.